TRACON Pharmaceutical (TCON) Tops Q4 EPS by 7c

TRACON Pharmaceutical (NASDAQ: TCON) reported Q4 EPS of ($0.01), $0.07 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $3.05 million versus the consensus estimate of $1.5 million.

For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c